[Federal Register Volume 67, Number 152 (Wednesday, August 7, 2002)]
[Notices]
[Pages 51287-51288]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-19868]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB Review; Comment Request; HIV Vaccine Awareness 
Study-Americans' Attitudes

SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork 
Reduction Act of 1995, the National Institutes of Allergy and 
Infectious Diseases (NIAID), the National Institutes of Health (NIH) 
has submitted to the Office of Management and Budget (OMB) a request 
for review and approval of the information collection listed below. 
This proposed information collection was previously published in the 
Federal Register on November 28, 2001, pages 59438-59439 and allowed 
60-days for public comment. No comments were received. The purpose

[[Page 51288]]

of this notice is to allow an additional 30 days for public comment. 
The National Institutes of Health may not conduct or sponsor, and the 
respondent is not required to, an information collection that has been 
extended, revised, or implemented on or after October 1, 1995, unless 
it displays a currently valid OMB control number.
    Proposed Collection: Title: HIV Vaccine Awareness Study-Americans' 
Attitudes. Type of Information Collection Request: New. Need and Use of 
Information Collection: NIH/NIAID/DAIDS is in the process of planning a 
campaign to inform Americans about HIV preventive vaccine research. As 
part of planning, it is necessary to establish a baseline of Americans' 
levels of knowledge and attitudes with respect to HIV preventive 
vaccine research; to determine what information is required by 
communities to address the mistrust, myths, and misinformation about 
HIV vaccine research; and to identify how and what information should 
be provided to communities to promote more positive attitudes toward 
HIV vaccine research. Findings will help inform initial campaign 
decisions and serve to evaluate the effectiveness of the campaign's 
efforts. Frequency of Response: Two times. Affected Public: Individuals 
or households. Type of Respondents: Random samples of adults, including 
those considered at-risk for HIV and members of their social networks. 
The annual reporting burden is as follows:

----------------------------------------------------------------------------------------------------------------
                                                                     Estimated                       Estimated
                                                     Estimated       number of    Average burden   total annual
               Type of respondents                   number of     responses per     hours per     burden hours
                                                    respondents     respondent       response        requested
----------------------------------------------------------------------------------------------------------------
General Population Adults.......................           4,000               1             .25           1,000
HIV-Affected Adults.............................           3,000               1             .25             750
                                                 ---------------------------------------------------------------
    Total.......................................           7,000  ..............             .25           1,750
----------------------------------------------------------------------------------------------------------------

    The annualized cost to respondents is estimated at $17,500. There 
are no Capital Costs to report. There are no Operating or Maintenance 
Costs to report.
    Request for Comments: Written comments and/or suggestions from the 
public and affected agencies are invited on one or more of the 
following points: (1) Whether the proposed collection of information is 
necessary for the proper performance of the function of the agency, 
including whether the information will have practical utility; (2) The 
accuracy of the agency's estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (3) Ways to enhance the quality, utility, and 
clarity of the information to be collected; and (4) Ways to minimize 
the burden of the collection of information on those who are to 
respond, including the use of appropriate automated, electronic, 
mechanical, or other technological collection techniques or other forms 
of information technology.
    Direct Comments to OMB: Written comments and/or suggestions 
regarding the item(s) contained in this notice, especially regarding 
the estimated public burden and associated response time, should be 
directed to the: Office of Management and Budget, Office of Regulatory 
Affairs, New Executive Office Building, Room 10235, Washington, DC 
20503, Attention: Desk Officer for NIH. To request more information on 
the proposed project or to obtain a copy of the data collection plans 
and instruments, contact Robert J. Gulakowski, Health Sciences 
Communications Specialist, DAIDS, NIAID, NIH, 6700-B Rockledge Drive, 
MSC 7620, Room 4144, Bethesda, MD 20892-7620, or call non-toll free 
(301) 496-0545, or E-mail your request, including your address to 
[email protected].
    Comments Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 30-days 
of the date of this publication.

    Dated: July 31, 2002.
Brenda J. Velez,
Chief, CMB, NIAID and NIAID Project Clearance Liaison.
[FR Doc. 02-19868 Filed 8-6-02; 8:45 am]
BILLING CODE 4140-01-M